Adapting Treatment Delivery to Improve Retention in Evidence-Based PTSD Treatment (CDA 21-191)
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Enrollment
- 30
- Locations
- 1
- Primary Endpoint
- Acceptability of Intervention (AIM)
Study Overview
Brief Summary
Posttraumatic stress disorder (PTSD) is prevalent among Veterans and effective evidence-based psychotherapies (EBPs) for PTSD have been implemented within the Veterans Health Administration (VHA). However, retention in PTSD EBPs is poor. Premature dropout is associated with worse clinical outcomes and greater healthcare utilization. Delivery of PTSD EBPs in a massed format, typically three or more days per week delivered within a month, have shown promise for increasing retention. The present study is a pilot feasibility and acceptability study comparing massed PTSD treatment to treatment as usual (e.g., typically weekly treatment).
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Single (Outcomes Assessor)
Masking Description
Clinical interviewers who assess primary outcomes will not be informed of participant's randomization assignment.
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Veterans aged 18 years or older;
- •meets criteria for current PTSD;
- •willingness to be randomized to either condition (e.g., EBP-Massed or EBP-TAU);
- •decision to receive CPT or PE in a treatment planning session with a Durham Trauma Recovery Program clinic provider;
- •ability to provide informed consent
Exclusion Criteria
- •High acute suicide risk;
- •active manic symptoms that would likely interfere with treatment;
- •active psychotic symptoms that would likely interfere with treatment;
- •currently in a concurrent trauma-focused evidence-based treatment for PTSD
Arms & Interventions
EBP-Massed
PTSD evidence-based psychotherapies are delivered in a massed format (e.g., intended be delivered at least three times per week).
Intervention: EBP-Massed (Other)
EBP-TAU
PTSD evidence-based psychotherapies are delivered treatment as usual, which is typically once per week.
Intervention: EBP-TAU (Other)
Outcomes
Primary Outcomes
Acceptability of Intervention (AIM)
Time Frame: Immediately after treatment completion or discontinuation (weeks 0-20)
Veterans' perceived acceptability of massed treatment for PTSD; scale score ranges from 1-5; greater score = greater acceptability
Clinician Administered PTSD Scale for DSM-5 (CAPS-5) Severity Score
Time Frame: 3 Month Follow up
PTSD Symptom Severity - Clinician Assessed; range 0-80; higher scores = greater severity.
Treatment completion
Time Frame: Immediately after treatment completion or discontinuation (weeks 0-20)
Proportion of Veterans who complete a full course of an assigned PTSD treatment
Client Satisfaction Questionnaire-8 (CSQ-8)
Time Frame: Post-treatment (weeks 0-20)
Veterans' perceived satisfaction of assigned treatment; range 8-32; greater scores = greater satisfaction
Clinician Administered PTSD Scale for DSM-5 (CAPS-5) Severity Score
Time Frame: Post-treatment (weeks 0-20)
PTSD Symptom Severity - Clinician Assessed; range 0-80; higher scores = greater severity.
Secondary Outcomes
- Brief Inventory of Psychosocial Functioning (BIPF)(3 Month Follow up)
- Session attendance(Post-treatment (weeks 0-20))
- Patient Health Questionnaire-9 (PHQ-9)(3 Month Follow Up)
- Patient Health Questionnaire-9 (PHQ-9)(Post-treatment (weeks 0-20))
- Brief Inventory of Psychosocial Functioning (BIPF)(Post-treatment (weeks 0-20))